Molecular evidence connecting an absence of expression of MLH1 with tumour-specific promoter hypermethylation in EH has previously been described, suggesting ECs with MSI may acquire this feature as precancers (Jovanovic et al., 1996). This evidence concerns the gene MLH1 and neoplasm.